Marker Therapeutics, Inc. (MRKR)
NASDAQ: MRKR · Real-Time Price · USD
1.420
-0.030 (-2.07%)
Apr 28, 2026, 4:00 PM EDT - Market closed
Marker Therapeutics Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -12.16 | -10.73 | -8.24 | -29.93 | -41.88 | |
| Depreciation & Amortization | - | - | - | - | 3.16 | |
| Stock-Based Compensation | 0.54 | 0.25 | 0.86 | 3.3 | 5.96 | |
| Other Operating Activities | - | - | -5.81 | -0.28 | - | |
| Change in Accounts Receivable | 0.98 | -1.32 | 1.37 | -2.4 | 1 | |
| Change in Accounts Payable | -0.45 | 0.01 | -0.72 | -1.32 | 4.14 | |
| Change in Unearned Revenue | 0.97 | - | - | -1.15 | 1.15 | |
| Change in Other Net Operating Assets | -1.89 | 0.89 | 2.19 | 0.1 | -0.82 | |
| Operating Cash Flow | -12.01 | -10.91 | -16.44 | -26.97 | -27.28 | |
| Capital Expenditures | - | - | - | - | -3.13 | |
| Other Investing Activities | - | - | 18.66 | -4.95 | - | |
| Investing Cash Flow | - | - | 18.66 | -4.95 | -3.13 | |
| Issuance of Common Stock | 9.86 | 14.99 | 1.11 | 0.2 | 52.56 | |
| Financing Cash Flow | 9.86 | 14.99 | 1.11 | 0.2 | 52.56 | |
| Net Cash Flow | -2.15 | 4.08 | 3.33 | -31.72 | 22.14 | |
| Free Cash Flow | -12.01 | -10.91 | -16.44 | -26.97 | -30.41 | |
| Free Cash Flow Margin | -338.74% | -165.53% | -496.51% | -767.66% | -2449.11% | |
| Free Cash Flow Per Share | -0.79 | -1.22 | -1.87 | -3.23 | -3.98 | |
| Levered Free Cash Flow | -8.6 | -7.13 | -10.14 | -14.77 | -12.98 | |
| Unlevered Free Cash Flow | -8.6 | -7.13 | -10.14 | -14.77 | -12.98 | |
| Change in Working Capital | -0.39 | -0.42 | 2.85 | -4.76 | 5.47 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.